Ahead of there ended up any instances of novel coronavirus confirmed in South Korea, a single of the country’s biotech corporations had begun planning to make screening kits to discover the disorder.

On January 16, Chun Jong-yoon, the chief government and founder of molecular biotech company Seegene, explained to his staff it was time to begin concentrating on coronavirus.

That was in advance of the virus sweeping China had been named Covid-19 and 4 times forward of South Korea confirming its very first case.

“Even if nobody is asking us to, we are a molecular diagnosis company. We have to get ready in progress,” he remembered wondering at the time.

Speedy forward two months, and South Korea is between the world’s worst impacted international locations, with just about 8,000 persons infected, in accordance to the Environment Wellbeing Firm.

But 1 explanation why South Korea may have a better quantity of bacterial infections than other nations around the world is its aggressive strategy to tests.

Even though some nations have struggled to get enough exam kits to diagnose suspected patients, South Korea has offered absolutely free and uncomplicated access to testing for any person who a medical doctor deems requirements it. To date, the nation has tested more than 230,000 people.

Part of the motive it was able to do that is the availability of exam kits developed by firms like Seegene.

Examine the entire story of how Seegene produced its check kits listed here.